2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Neoplasms
9
Breast Neoplasms
6
Lymphoma, B-Cell, Marginal Zone
4
Barrett Esophagus
4
Lymphoma, Large B-Cell, Diffuse
3
Inflammation
3
Head and Neck Neoplasms
3
Zollinger-Ellison Syndrome
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Stomach Ulcer
1
Solid Tumours
1
Solid Tumor
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Prostate Cancer Patients
1
Precancerous Gastric Lesions
1
Pharmacokinetics of MDV3100
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Obesity
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Interventions
Exercise
25
Metformin
23
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
8
Surveys and Questionnaires
6
Early Intervention, Educational
6
Caloric Restriction
6
semaglutide
5
Liraglutide
5
Exenatide
5
Diet, Mediterranean
5
Blood Specimen Collection
5
Educational Status
4
Docosahexaenoic Acids
4
Bariatric Surgery
4
exemestane
3
Vitamin D
3
Therapeutics
3
Tamoxifen
3
Sugars
3
Standard of Care
3
Observation
3
Naltrexone
3
Letrozole
3
Dexamethasone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obesity
×
Omeprazole
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled